Effect Of Kasmaryadi Kashaya In The Management of Elevated Serum Uric acid level.
Phase 2
- Conditions
- Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
- Registration Number
- CTRI/2024/07/069896
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Subjects in the age group between 18-60 years having elevated Serum uric acid
level above 6.8 mg/dL.
2) Subjects irrespective of gender and socio-economic status.
3) Subjects who are willing to sign the consent form.
Exclusion Criteria
1) Pregnant and lactating women.
2) Subjects with known cases of Malignancy, Diabetes mellitus, any Concurrent
Hepatic disorders, Chronic Renal failure, Hyperthyroidism and Hypothyroidism
3) Subjects on medication with aspirin (low dose 1-2 g per day), beta blockers and
alpha -1 blockers for hypertension, antidepressants, modern diuretics and on
medication of hyperuricemia.
4) Known alcoholic subjects and subjects consuming high purine diet.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the efficacy of Kasmaryadi Kwatha in the management of Hyperuricemia <br/ ><br>2.To assess the efficacy of Kasmaryadi Kwatha in reducing symptoms of symptomatic <br/ ><br>patients using Brief Pain Inventory Scale and in improving quality of life assessed by <br/ ><br>Bengali version of Questionnaire assessing impact of hyperuricemia on quality of lifeTimepoint: 1.Serum Uric acid test. <br/ ><br>2.Pain (Assessed by brief pain inventory scale) <br/ ><br>3.Quality of life (Assessed by Bengali version of questionnaire assessing impact of <br/ ><br>hyperuricemia on quality of life). <br/ ><br> <br/ ><br>Assessment will be done on 0th day, 8th day, 16th day and 31st day
- Secondary Outcome Measures
Name Time Method To assess the safety of Kasmaryadi Kwatha in subjects diagnosed with Hyperuricemia. <br/ ><br>Timepoint: Liver Function Test,Renal Function Test,Random Blood Sugar and Blood Routine Examination with ESR will be done on 0th and 16th day to assess safety